Abstract
IntroductionConsidering the high prevalence of polypharmacy in pregnant women and the knowledge gap in the risk–benefit safety profile of their often-complex treatment plan, more research is needed to optimise prescribing....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have